Clinical Trial: Long Term Prevention of Nausea and Vomiting in Gynecologic Laparoscopy
Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional
Official Title: A Randomized Prospective Study of Scheduled Intravenous Ramosetron for the Prevention of Nausea and Vomiting in Hospitalized Patients After Gynecologic Laparoscopy
Brief Summary:
To compare postoperative nausea and vomiting (PONV) and perioperative outcomes of gynecologic patients undergoing laparoscopic surgery after scheduled administration of intravenous Ramosetron during hospital stays.
- Randomized controlled arm : Placebo versus Ramosetron injection
- Administration schedule : immediate postoperative status, 12 hrs after surgery, 36hrs after surgery
Detailed Summary: Surgical outcomes including operative time, blood loss, Hb change, postoperative pain, nausea/vomiting scale, times of rescue therapy, and complications
Sponsor: National Health Insurance Service Ilsan Hospital
Current Primary Outcome: Incidence or intensity of PONV [ Time Frame: during postoperative hospital stays (2 days) ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Adverse reaction associated with Ramosetron injection [ Time Frame: Postoperatvie 7 days (at OPD based) ]
Original Secondary Outcome: Same as current
Information By: National Health Insurance Service Ilsan Hospital
Dates:
Date Received: December 10, 2013
Date Started: November 2013
Date Completion:
Last Updated: December 12, 2013
Last Verified: December 2013
